Announced
Completed
AIMMUNE THERAPEUTICS INC / NESTLE / Acquisition / Public
Synopsis
Equity investment in Aimmune Therapeutics, a biopharmaceutical company developing CODIT™ (Characterized Oral Desensitization ImmunoTherapy), by Nestlé Health Science.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite